<turbo-stream action="append" target="news"><template>  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positive
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Hims-Hers-Health-Inc-US4330001060">Hims &amp; Hers Health Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Invezz</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">3 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://invezz.com/news/2026/07/01/hims-hers-stock-jumps-as-canaccord-lifts-target-ahead-of-fda-review/?utm_source=snapi">Hims &amp; Hers stock jumps as Canaccord lifts target price ahead of FDA review</a>
    </div>

      <div class="me-0 me-md-5">
        Hims &amp; Hers Health shares (HIMS) surged 9% on Wednesday after Canaccord Genuity raised its price target on the telehealth company, citing improving sales trends, momentum in its weight-loss business, and growing optimism around its peptide opportunity. Canaccord analyst Maria Ripps maintained a Buy rating on the stock while increasing her price target to $40 from $32, implying additional upside...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positive
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Hims-Hers-Health-Inc-US4330001060">Hims &amp; Hers Health Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Reuters</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">3 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.reuters.com/legal/litigation/hims-obesity-drug-business-may-get-boost-employers-drop-coverage-2026-06-25/">Hims&#39; obesity drug business may get boost as employers drop coverage</a>
    </div>

      <div class="me-0 me-md-5">
        Telehealth provider Hims and Hers Health may get a boost next year from employers dropping coverage of weight-loss drugs like Novo Nordisk&#39;s Wegovy and Eli Lilly&#39;s Zepbound and Foundayo ​to rein in costs, investors and analysts say.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positive
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Hims-Hers-Health-Inc-US4330001060">Hims &amp; Hers Health Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Barrons</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.barrons.com/articles/abbott-healthcare-stocks-price-buy-43de013b">Living Longer Is Big Business. These Stocks Will Benefit.</a>
    </div>

      <div class="me-0 me-md-5">
        TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Hims-Hers-Health-Inc-US4330001060">Hims &amp; Hers Health Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260604732825/en/Hims-Hers-Names-Dr.-Anant-Vinjamoori-as-Chief-Medical-Officer-of-Hims/">Hims &amp; Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims</a>
    </div>

      <div class="me-0 me-md-5">
        SAN FRANCISCO--(BUSINESS WIRE)--Hims &amp; Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of ...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Hims-Hers-Health-Inc-US4330001060">Hims &amp; Hers Health Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260602648634/en/Hims-Hers-Completes-Acquisition-of-Eucalyptus-Accelerating-Its-Push-to-Transform-Healthcare-for-Canadians/">Hims &amp; Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians</a>
    </div>

      <div class="me-0 me-md-5">
        TORONTO--(BUSINESS WIRE)--Hims &amp; Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims &amp; Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligible Canadians. By combining Jun...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Hims-Hers-Health-Inc-US4330001060">Hims &amp; Hers Health Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260602317273/en/Hims-Hers-Completes-Acquisition-of-Eucalyptus-Parent-Company-of-Juniper-Officially-Entering-Japanese-Market/">Hims &amp; Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market</a>
    </div>

      <div class="me-0 me-md-5">
        TOKYO--(BUSINESS WIRE)--Hims &amp; Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company&#39;s global growth and its formal entry into Japan. This milestone puts the full weight of Hims &amp; Hers&#39; technology, data, and clinical infrastructure behind a platform that supports weight management care for people in Japan, a ...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Hims-Hers-Health-Inc-US4330001060">Hims &amp; Hers Health Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260602926942/en/Hims-Hers-Completes-Acquisition-of-Eucalyptus-Expanding-Access-to-Comprehensive-Clinically-Backed-Weight-Management-Care-in-Germany/">Hims &amp; Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany</a>
    </div>

      <div class="me-0 me-md-5">
        BERLIN--(BUSINESS WIRE)--Hims &amp; Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, advancing its position as the world&#39;s largest consumer health platform. In Germany, the closing strengthens Juniper&#39;s comprehensive, clinically rigorous, weight management offering with the technology, data, and infrastructure of Hims &amp; Hers behind it. Since launching in...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Hims-Hers-Health-Inc-US4330001060">Hims &amp; Hers Health Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260602264452/en/Hims-Hers-Completes-Acquisition-of-Eucalyptus-Advancing-Position-as-the-Worlds-Largest-Consumer-Health-Platform/">Hims &amp; Hers Completes Acquisition of Eucalyptus, Advancing Position as the World&#39;s Largest Consumer Health Platform</a>
    </div>

      <div class="me-0 me-md-5">
        SYDNEY--(BUSINESS WIRE)--Hims &amp; Hers Health, Inc. has completed its acquisition of Eucalyptus – the parent company of Juniper, Pilot, Kin, and Software – advancing its position as the world&#39;s largest consumer health platform and marking its official entry into Australia. This milestone puts the full weight of Hims &amp; Hers&#39; technology, data, and clinical infrastructure behind a platform that has ...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

</template></turbo-stream><turbo-stream action="replace" target="link"><template><div id="link">
    <a class="btn btn-outline-primary btn--small" data-turbo-stream="" href="/en/news/Hims-Hers-Health-Inc-US4330001060/load_more?page=6">
      Show more News
      <i class="fa fa-arrow-down fa-fw"></i>
</a></div>
</template></turbo-stream>